Investigation Effect of Glimepiride on Diabetic Marker and Cardiac Lipid Parameter in Isoproterenol Induced Myocardial Infarction in Diabetes in Rats
Keywords:
Glimepiride, Glucose, HbA1c, lip id profile, lipid metabolic enzymesAbstract
Present study was designed to evaluate effect Glimepiride on Glucose, HbA1c, lipid profile and Lipid Metabolizing Enzymes in isoproterenol induced myocardial infarction in normal and Streptozotocin-Nicotinamide induced in diabetic rats. Glimepiride (0.5 mg/kg, p.o) was administered for 28 days in rats injected with single dose of Streptozotocin (65 mg/kg, i.p, STZ) and Nicotinamide (110 mg/kg, i.p, NIC) and after isoproterenol (200 mg/kg, s.c.) induced myocardial infarction in rats on 29th and 30th day. At the end of experimental period (i.e. on the day 31) serum and heart tissues sample were collected, and glucose, HbA1c and Total Cholesterol (TC), Triglycerides (TG) and High density lipoprotein (HDL) and cholesterol ester synthetase (CES), lecithin Cholesterol acyl transferase (LCAT), lipoprotein lipase (LPL) were find out. Administration of STZ–NIC in rats showed a significant (p<0.001) increased in the levels of serum glucose, glycosylated heamoglobin (HbA1c), Total Cholesterol (TC), Triglycerides (TG) and Low density lipoprotein (LDL) whereas the levels of High density lipoprotein (HDL) were found to be non significant but significant (p<0.001) increased in the level of heart tissues CES and significant (p<0.001, p<0.01) decreased LCAT and LPL as compared to respective control groups. Treatment with Glimepiride significantly (P<0.001) decreased HbA1c, glucose, CES level and significantly (P<0.001, P<0.05, P<0.05) decreased LDL, TC and TG and significant (P<0.01) increased LCAT and LPL level but no significantly change HDL in compared to diabetic control group. This study suggested that GLI (0.5 mg/kg) is effective in controlling blood glucose levels and improves lipid profile and lipid metabolizing enzymes in experimentally induced myocardial infarction diabetic rats.
References
Kahn SE, Porte DJ. The pathophysiology of
type II (noninsulin-dependent)
diabetes mellitus: Implications for treatment.
In: Rifkin H, Porte DJ, eds. Ellenberg and
Rijkin’s Diabetes Mellitus: Theory and
Practice. New York: Elsevier Science
:436-456.
Leibowitz HE. Oral hypoglycemic agents. In:
Rifkin H, Porte DJ, eds. Ellenberg nd
Rijkin’s Diabetes Mellitus: Theory and
Practice. New York: Elsevier Science
:554-574.
Uemura S, Matsushita H, Li W, Glassford
AJ, Asagami T, Lee KH, et al 2001.
Diabetes mellitus enhances vascular matrix
metalloproteinase activity: role of oxidative
stress. Circ Res 88:1291-8.
Senses V, Ozyazgan S, Ince E, Tuncdemir
M, Kaya F, Ozturk M, et al 2001. Effect of
-aminoimidazole-4-carboxamide riboside
(AICA-r) on isolated thoracic aorta
responses in streptozotocin-diabetic rats. J
Basic Clin Physiol Pharmacol 12:227– 48.
Benelli R,Vene R, Bisacchi D, Garbisa S,
Albini A. Anti-invasive effects of green tea
polyphenol epigallocatechin-3-gallate, a
natural inhibitor of metallo and serine
prostate. Biol Chem. 2002; 382: 101–105.
Prince PS, Rajadurani M. Preventive effect
of Aegle marmelos leaf extract on
isoproterenol- induced myocardial infarction
in rats-Biochemical evidence. J Pharm
Pharmacol. 2005; 57: 1353–1357.
Sathish V, Ebenezar KK, Devika T.
Biochemical changes on the cardioprotective
effect of nicorandil and amlodipin during
experimental myocardial infarction in rats.
Pharmacol Res. 2003; 48: 565–570.
Masiello, P., Broca, C., Gross, R., Roye, M.,
Manteghetti, M., Hillaire-Buys, D., Novelli,
M., Ribes, G. Experimental NIDDM:
development of a new model in adult rats
administered Streptozotocin and
Nicotinamide. Diabetes 1998, 47; 224–229.
Kothari HV, Miller BF, Kritchevsky D.
Aortic cholesterol esterase: characteristics of
normal rat and rabbit enzyme. Biochem
Biophys Acta. 1973; 296: 446–454.
Hitz J, Steinmetz J, Siest G. Plasma lecithin:
cholesterol acyl transferase-referance values
and effects of xenobiotics. Clin Chim Acta.
; 133: 85–96.
Slater AM, White DA. Effect of dietary fat
on cholesterol metabolism: regulation of
plasma LDL concentrations. Nutr Res. 1996;
: 241–257.
Abel ED 2005. Myocardial insulin
resistance and cardiac complications of
diabetes. Curr Drug Targets Immune Endocr
Metabol Disord Jun;5(2):219-26.
Paulsen, E.P. Heamoglobin A1C in
childhood of diabetes. Metabolism 1973; 22:
- 271.
Koening, R.L., Peterson, C.M. Jones, R.L.
Saudek, C. Lehrman, M. and Cerami, A.
Correlation of glucose regulation and
hemoglobin A1C in diabetes mellitus. New
England Journal of Medicine 1976; 295:
-420.
Gabbay, K.H. Glycosylated hemoglobin and
diabetic control. New England Journal
Medicine 1976; 95: 443-454.
Nestel PJ, Havel RJ, Bezman A. Metabolism
of constituent lipids of dog chylomicrons. J
Clin Invest. 1963; 42: 1313–1321.
Upaganlawar A, Gandhi C, Balaraman R.
Effect of green tea and vitamin E
combination on isoproterenol induced
myocardial infarction in rats. Plant Foods
Human Nutri. 2009; 64: 75–80.
